Clinical Trial Update: A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC) [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 dose-finding study evaluating pertuzumab in combination with trastuzumab in healthy male participants and wome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Early Breast Cancer | Phase 1 | Status: COMPLETED